Amlodipine/Valsartan Single-Pill Combination A Review of its Use in the Management of Hypertension

被引：17
作者：
Frampton, James E. [1 ]
Scott, Lesley J. [1 ]
机构：
[1] Adis, Auckland, New Zealand
来源：
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS | 2009年 / 9卷 / 05期
关键词：
CALCIUM-CHANNEL BLOCKER; FIXED-DOSE COMBINATION; HIGH BLOOD-PRESSURE; DOUBLE-BLIND; CARDIOVASCULAR EVENTS; STAGE-2; HYPERTENSION; INSULIN SENSITIVITY; ATRIAL-FIBRILLATION; VALSARTAN ADDITION; THERAPEUTIC-USE;
D O I：
10.2165/11201120-000000000-00000
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Single-pill combinations of the dihydropyridine calcium channel blocker (CCB) amlodipine and the angiotensin 11 receptor blocker valsartan (amlodipine/valsartan) [Exforge (R)] are available in the US for the treatment ofpatients with hypertension. Prescribing information for amlodipine/valsartan states that it may be used in patients whose BP is not adequately controlled on either component monotherapy, and as initial therapy in patients who are likely to need multiple drugs to achieve their BP goals.
引用
收藏
页码：309 / 330
页数：22
相关论文
共 66 条
[1]   Efficacy of the Combination of Amlodipine and Valsartan in Patients With Hypertension Uncontrolled With Previous Monotherapy: The Exforge in Failure After Single Therapy (EX-FAST) Study [J].
Allemann, Yves ;
Fraile, Belen ;
Lambert, Michel ;
Barbier, Michaela ;
Ferber, Philippe ;
Izzo, Joseph L., Jr. .
JOURNAL OF CLINICAL HYPERTENSION, 2008, 10 (03) :185-194
[2]   Combined Therapy With a Calcium Channel Blocker and an Angiotensin II Type 1 Receptor Blocker [J].
Bakris, George L. .
JOURNAL OF CLINICAL HYPERTENSION, 2008, 10 (01) :27-32
[3]   Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy [J].
Brachmann, Johannes ;
Ansari, Anwar ;
Mahla, Gerhard ;
Handrock, Renate ;
Klebs, Sven .
ADVANCES IN THERAPY, 2008, 25 (05) :399-411
[4]   Use of single-pill combination therapy in the evolving paradigm of hypertension management [J].
Calhoun, David A. .
EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (12) :1869-1874
[5]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[6]   Using Fixed-Dose Combination Therapies to Achieve Blood Pressure Goals [J].
Chrysant, Steven G. .
CLINICAL DRUG INVESTIGATION, 2008, 28 (11) :713-734
[7]   A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure [J].
Cohn, JN ;
Tognoni, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) :1667-1675
[8]   Hypertension in blacks [J].
Cooper, R ;
Rotimi, C .
AMERICAN JOURNAL OF HYPERTENSION, 1997, 10 (07) :804-812
[9]   Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial [J].
Dahlöf, B ;
Sever, PS ;
Poulter, NR ;
Wedel, H ;
Beevers, DG ;
Caulfield, M ;
Collins, R ;
Kjeldsen, SE ;
Kristinsson, A ;
McInnes, GT ;
Mehlsen, J ;
Nieminen, M ;
O'Brien, E ;
Östergren, J .
LANCET, 2005, 366 (9489) :895-906
[10]  
*DAIICH SANK INC, 2007, AZ AML OLM MED TABL
1234567